<DOC>
	<DOCNO>NCT00386971</DOCNO>
	<brief_summary>Included study patient HIV treat highly active antiretroviral medication ( HAART ) include protease inhibitor ( PI ) non-nucleoside reverse transcriptase inhibitor ( NNRTI ) . Protease inhibitors non-nucleoside reverse transcriptase inhibitor common medication HIV treatment usually give medication part standard treatment HIV ( HAART ) . We hope learn level cholesterol-and triglyceride-carrying particle ( lipoprotein ) affect nutritional supplement , L-Carnitine , HIV-positive patient treat antiretroviral medication .</brief_summary>
	<brief_title>Effects L-Carnitine Postprandial Clearance Triglyceride-rich Lipoproteins HIV Patients HAART</brief_title>
	<detailed_description>The postprandial state proinflammatory proatherogenic condition . Increasing evidence support contention elevate triglyceride ( TG ) -rich lipoprotein ( TGRL ) atherogenic . Hypertriglyceridemia characteristic metabolic complication human immunodeficiency virus/highly active antiretroviral therapy ( HIV/HAART ) increase postprandial lipemia commonly see situation may convey increase cardiovascular risk . A possible contribution hypertriglyceridemia HIV/HAART may decrease mitochondrial function , result decrease fatty acid oxidation . A decrease mitochondrial function may also contribute insulin resistance . L- Carnitine play important role transfer long-chain acyl group mitochondrial matrix potentially improve energy metabolism . L- Carnitine show reduce hypertriglyceridemia HAART HIV-positive subject , virtually nothing known effect postprandial state . We experience postprandial study HAART-treated HIV-positive African American Hispanic subject , focus relationship lipid , fatty acid , insulin adipokines . This particular relevance among African Americans , key metabolic component differ substantially level Caucasians . Further , relationship metabolic parameter HIV/HAART far less explored ethnic group . We recently find proportional relationship insulin non-esterified fatty acid ( NEFA ) response food among African American HIV-positive subject . Further , show relationship fast insulin postprandial adipokine level . In randomized , double blind placebo-controlled pilot study , explore whether L- Carnitine affect TGRL metabolism fast postprandial state among African American Hispanic HIV-positive subject undergoing antiretroviral therapy . We hypothesize : ( 1 ) L- Carnitine supplementation improve fast TGRL level postprandial response , ( 2 ) L- Carnitine impact relationship insulin NEFA adipokines postprandial state . In specific aim , test effect L- Carnitine supplementation : - Baseline TGRL metabolism insulin , NEFA adipokine level - Postprandial TGRL responses postprandial relationship insulin non-esterified fatty acid ( NEFA ) adipokines We believe result generate proposed study help evaluate effect L- Carnitine supplementation postprandial TGRL-associated cardiovascular risk .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>Men Women Ages 1870 , Stable HAART regimen x 6 mo , PI NNRTI base regimen , Caucasian , African American Hispanic patient Diabetes Mellitus , Liver Disease , uncontrolled Pregnant nursing mother , BMI &gt; 35 , Hemoglobin &lt; 11 g/dl , Conditions know low seizure threshold ( ie . brain tumor ) take medication low seizure threshold , Patients take : Warfarin , ValproicAcid Zidovudine , Wellbutrin Effexor Chronic Kidney Disease Stage 35 , Untreated Thyroid Disease , Hormone replacement therapy , Triglycerides &gt; 500 mg/dl ( fast )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>L-carnitine</keyword>
	<keyword>HIV</keyword>
	<keyword>TGRL metabolism</keyword>
	<keyword>postprandial</keyword>
	<keyword>HIV Treatment Experienced</keyword>
</DOC>